(2R)-3-(2-Chloro-4-nitro-1H-imidazol-1-yl)-2-methyl-1,2-propanediol is an intermediate in the synthesis of Delamanid, a novel anti-tuberculosis medication that inhibits mycolic acid synthesis and shows potent in-vitro and in-vivo activity against drug-resistant strains of Mycobacterium tuberculosis.

CAS：681490-91-5
中文别名：
英文别名：(R)-2-chloro-1-(2,3-dihydroxy-2-methyl)propyl-4-nitroimidazole;
分子式：C7H10ClN3O4
分子量：235.625
精确质量：235.036
Psa：104.1
Logp：0.7112